Medicover revenue and financials

MCOV.B · Nasdaq Stockholm · SEK

Compare Medicover
kr 256.50Change from previous close: −0.97%Absolute change: −kr 2.50

Close · November 20, 2026

In the fiscal year ended December 2025, Medicover reported revenue of €2.38B (+13.69% year over year). Net income was €77.5M, a net margin of 3.3%.

Annual revenue · 2025: €2.38B
  1. €497.3M2016
  2. €580.2M2017
  3. €671.6M2018
  4. €844.4M2019
  5. €997.8M2020
  6. €1.38B2021
  7. €1.51B2022
  8. €1.75B2023
  9. €2.09B2024
  10. €2.38B2025

Fiscal year ending in December. Sources and method on the page How we analyse stocks.

At a glance

Revenue growth
+13.69%
2025 vs 2024
Net income growth
+364.07%
2025 vs 2024
Net margin
3.3%
2024: 0.8%

How Medicover is changing

Calculated from the annual statements; each fiscal year is labelled with the year it ends.

Financial data

Amounts in millions of EUR; per-share values in EUR; shares in millions.

Income statement · Annual
Item2025202420232022202120202019201820172016
Total revenue2,3782,0921,7461,5101,377998844672580497
Cost of revenue1,8271,6441,3871,170982734637507438377
Gross profit551448359340395264207164142120
Selling, general and administrative39435929827123219615812911398.9
Operating income15789.661.968.716368.049.735.528.821.1
EBIT15789.661.968.716368.049.735.528.821.1
EBITDA25818815615322111485.062.752.843.0
Interest expense64.058.851.434.520.118.113.79.64.94.6
Pre-tax income98.420.123.619.514437.333.331.728.012.3
Income tax25.75.55.25.837.210.08.67.57.85.8
Net income77.516.717.611.810225.822.522.318.74.3
Net income to common shareholders77.516.717.611.810225.822.522.318.74.3
Basic EPS0.510.110.120.080.690.180.170.170.160.05
Diluted EPS0.510.110.120.080.690.180.170.170.160.05
Average shares (basic)15115014914914814213313311995.0
Average shares (diluted)15115015014914814213313311996.8
Dividend per share0.200.150.120.120.120.07————

Companies in the group: same industry, similar size